Status:
COMPLETED
Glucosamine Sulfate Bioavailability
Lead Sponsor:
Isura
Conditions:
Bioavailability and Pharmacokinetics
Eligibility:
All Genders
21-65 years
Phase:
NA
Brief Summary
This study aims to compare the pharmacokinetics and bioavailability of crystalline glucosamine sulfate and regular glucosamine sulfate using a double-blind, randomized, crossover design.
Eligibility Criteria
Inclusion
- Male or female aged 21- 65 years
- Healthy, good physical condition
- Voluntary, written, informed consent to participate in the study.
Exclusion
- Serious acute or chronic diseases e.g. liver, kidney, or gastrointestinal diseases
- Use of medications affecting glucosamine metabolism
- Known allergies to shellfish or glucosamine
- Pregnancy or breastfeeding
- Participation in another investigational study
Key Trial Info
Start Date :
January 6 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2025
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06971484
Start Date
January 6 2025
End Date
April 30 2025
Last Update
May 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ISURA
Burnaby, British Columbia, Canada